Search for content and authors
 

- Joanna Zagrodzka

e-mail:
phone: +48-22-4563905
fax:
web:
interest(s):

Affiliation:

Instytut Farmaceutyczny

address: Rydygiera 8, Warszawa, 01-793, Poland
phone: +48-22-4563900
fax: +48-22-4563838
web: http://www.ifarm.waw.pl

Participant:

V Multidyscyplinarna Konferencja Nauki o Leku

began: 2006-05-15
ended: 2006-05-17
Presented:
V Multidyscyplinarna Konferencja Nauki o Leku
HPLC AS A METHOD FOR ANALYTICAL CONTROL OF SYNTHESIS AND DETERMINATION OF PRAMIPEXOLE

Participant:

VI Multidyscyplinarna Konferencja Nauki o Leku

began: 2008-05-25
ended: 2008-05-29
Presented:
VI Multidyscyplinarna Konferencja Nauki o Leku
HPLC as a method for analytical control of synthesis and determination of tolterodine (TD-S)

Participant:

VII Multidyscyplinarna Konferencja Nauki o Leku

began: 2010-05-09
ended: 2010-05-13
Presented:
VII Multidyscyplinarna Konferencja Nauki o Leku
HPLC method as an analitycal control of synthesis and determination of TZ-S
VII Multidyscyplinarna Konferencja Nauki o Leku
Analytical control of synthesis and determination of BR-S by HPLC

Participant:

VIII Multidyscyplinarna Konferencja Nauki o Leku

began: 2012-05-29
ended: 2012-06-02
Presented:

Participant:

IX Multidyscyplinarna Konferencja Nauki o Leku

began: 2014-05-11
ended: 2014-05-15
Presented:
IX Multidyscyplinarna Konferencja Nauki o Leku
Determination of organic volatile impurities in Nepafenac by GC method

Publications:
  1. Analytical control of synthesis and determination of BR-S by HPLC
  2. An application of accelerator mass spectrometry (AMS) in pediatric clinical studies. Paracetamol, midazolam and spironolactone radiosynthesis and certification.
  3. Application of the new data processing method for photodiode array detector in the analysis of drug substances
  4. Comparative permeation studies of tacalcitol through the human skin from brand product versus generic product
  5. Determination of organic volatile impurities in Nepafenac by GC method
  6. Development and validation of HPLC method. Review of selected cases.
  7. Development and validation of the HPLC-UV method for impurities determination in duloxetine hydrochloride
  8. Development of HPLC and GC methods for analysis of Zolmitriptan of pharmaceutical purity
  9. HPLC AS A METHOD FOR ANALYTICAL CONTROL OF SYNTHESIS AND DETERMINATION OF PRAMIPEXOLE
  10. HPLC as a method for analytical control of synthesis and determination of tolterodine (TD-S)
  11. HPLC method as an analitycal control of synthesis and determination of TZ-S
  12. HPLC method for determination of the enantiomeric purity of a new ω chain aldehyde synthon used in the synthesis of travoprost
  13. HPLC methods for in–process control and chemical purity determination of olopatadine
  14. Identification of degradation products of cilostazol drug substance
  15. Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. 
  16. The synthesis of ezetimibe with high stereochemical purity
  17. Validation of HPLC methods for analyzing the chemical purity of cilostazol
  18. Zolmitriptan synthesis and in-process control by HPLC methods



Google
 
Web science24.com
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine